7-Aminocephalosporanic Acid (7-ACA) Market Revenue 2024 to 2034
7-Aminocephalosporanic Acid (7-ACA) Market Revenue 2024 to 2034
The global 7-Aminocephalosporanic Acid (7-ACA) market was estimated at US$ 671.2 million in 2023 and is projected to grow to US$ 1,264.68 million by 2034, rising at a compound annual growth rate (CAGR) of 5.54% from 2024 to 2034. The demand for 7-ACA is high in the market because it is a core component for the synthesis of cephalosporin.
Report ID: 10272
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 671.20 Mn
Forecast Year,
USD USD 981.59 Mn
CAGR, 2025 -
5.54%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
7-Aminocephalosporanic Acid (7-ACA) Market Size Analysis
7-Aminocephalosporanic Acid (7-ACA) Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Enzymatic Hydrolysis | 438.33 | 462.18 | 487.32 | 513.84 | 541.80 | 571.28 | 602.38 | 635.17 | 669.75 | 706.22 | 744.67 |
| Chemical Cracking | 232.87 | 246.21 | 260.31 | 275.21 | 290.96 | 307.61 | 325.21 | 343.81 | 363.46 | 384.23 | 406.19 |
7-Aminocephalosporanic Acid (7-ACA) Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ceftriaxone | 237.72 | 250.28 | 263.51 | 277.45 | 292.14 | 307.61 | 323.92 | 341.10 | 359.20 | 378.28 | 398.37 |
| Cefazolin | 167.80 | 177.10 | 186.91 | 197.26 | 208.19 | 219.72 | 231.90 | 244.74 | 258.30 | 272.61 | 287.72 |
| Ceftazidime | 132.84 | 140.51 | 148.61 | 157.17 | 166.22 | 175.78 | 185.89 | 196.57 | 207.85 | 219.78 | 232.39 |
| Cefotaxime | 132.84 | 140.51 | 148.61 | 157.17 | 166.22 | 175.78 | 185.89 | 196.57 | 207.85 | 219.78 | 232.39 |
7-Aminocephalosporanic Acid (7-ACA) Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 204.89 | 215.47 | 226.60 | 238.32 | 250.67 | 263.67 | 277.36 | 291.77 | 306.95 | 322.94 | 339.78 |
| Asia Pacific | 169.57 | 178.57 | 188.06 | 198.07 | 208.61 | 219.72 | 231.44 | 243.78 | 256.80 | 270.52 | 284.98 |
| Europe | 169.57 | 178.57 | 188.06 | 198.07 | 208.61 | 219.72 | 231.44 | 243.78 | 256.80 | 270.52 | 284.98 |
| Latin America | 63.59 | 67.89 | 72.45 | 77.29 | 82.43 | 87.89 | 93.68 | 99.82 | 106.33 | 113.24 | 120.57 |
| Middle East and Africa | 63.59 | 67.89 | 72.45 | 77.29 | 82.43 | 87.89 | 93.68 | 99.82 | 106.33 | 113.24 | 120.57 |
7-Aminocephalosporanic Acid (7-ACA) Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
